午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook Chinese Germany Japanese Korean

上海一飛生物科技有限公司 Company Information
Company Name:    Shanghai Yifei Biotechnology Co. , Ltd.
Tel:    021-65675885
Email:    customer_service@efebio.com
Nationality:    China
WebSite:    http://www.efebio.com
Product List:    11973
91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Product List
Brentuximab 2088770-90-3
BI-6901 2040401-92-9
PDD00031705 2032096-45-8
Atorolimumab 202833-08-7
Lenvervimab 2055006-79-4
UNC2025 hydrochloride 2070015-17-5
PFB-FDGlu 209540-62-5
Upacicalcet sodium 2052969-18-1
S5A1 2055882-51-2
Pitavastatin D4 2070009-71-9
WAY-239196 205749-56-0
EGFR-IN-99 2068806-31-3
Golexanolone 2089238-18-4
Coleneuramide 204200-47-5
Ticalopride 202590-69-0
Tepoditamab 2044679-53-8
Belantamab 2061894-48-0
Rolinsatamab 2095467-30-2
PF-06843195 2067281-51-8
AZ506 2043321-54-4
TU-2100 207972-39-2
BMS-195270 202822-23-9
Cetrelimab 2050478-92-5
SM1-71 2088179-99-9
PF-06445974 2055776-17-3
PU-H71 HCl 2095432-24-7
Seclidemstat mesylate 2044953-70-8
Claficapavir 2055732-24-4
BTM-3528 2054998-45-5
Kras4B G12D-IN-1 2042365-85-3
2,4-D-d3 202480-67-9
Allopregnanolone-d4 203805-85-0
XMU-MP-2 2031152-10-8
Vopratelimab 2039148-04-2
Ravagalimab 2050816-56-1
CMX-521 2077178-99-3
TV 3279 209394-29-6
TBI-223 2071265-08-0
Casein Kinase inhibitor A86 2079069-01-3
GSK269962A hydrochloride 2095432-71-4
beta-Endosulfan-d4 203716-99-8
Tuvatexib 2055404-90-3
Tovinontrine 2062661-53-2
Palazestrant 2092925-89-6
XMU-MP-3 2031152-08-4
ERK-IN-3 benzenesulfonate 2055597-39-0
F13714 fumarate 208109-39-1
TNF-α-IN-9 2054199-25-4
HDAC-IN-52 2075787-77-6
D-Ribose 5-phosphate disodium dihydrate 207671-46-3
VT-1598 2089320-99-8
Prolgolimab 2093956-19-3
Quetmolimab 2084037-83-0
Posenacaftor sodium 2095064-06-3
Tilpisertib 2065153-41-3
Rolusafine 2089153-78-4
Avexitide acetate 2051593-46-3
Iroxanadine 203805-20-3
Epratuzumab 205923-57-5
SR9011 hydrochloride 2070014-94-5
OTS193320 2093401-33-1
Izencitinib 2051918-33-1
Morolimumab 202833-07-6
Sutimlimab 2049079-64-1
Lingdolinurad 2088176-96-7
Anticancer agent 7 2088956-21-0
IRAK4-IN-8 2033070-97-0
FD223 2050524-24-6
Nesuparib 2055357-64-5
PSB-16133 sodium 2089035-40-3
(R)-Posenacaftor sodium 2095064-09-6
BAY 1892005 2036352-13-1
(R)-Azasetron besylate 2025360-91-0
(Rac)-LB-100 2061038-65-9
Eflucimibe 202340-45-2
Iscalimab 2031153-61-2
Abrezekimab 2043952-59-4
Murlentamab 2058047-65-5
Levilimab 2035008-70-7
MAX-40279 2070931-57-4
GSK3494245 2080410-41-7
EWP 815 20231-01-0
BTX161 2052301-24-1
K67 2046250-48-8
JHU395 2079938-92-2
Mitazalimab 2055640-86-1
Osocimab 2056878-75-0
Cinpanemab 2094516-02-4
Retifanlimab 2079108-44-2
Mal-amido-PEG3-NHS ester 2055353-77-8
BMS-986224 2055200-88-7
AM-8123 2049973-02-4
Tz-Thalidomide 2087490-42-2
Sirpiglenastat 2079939-05-0
Pumafentrine 207993-12-2
Azelaprag 2049980-18-7
USP30 inhibitor 11 2067332-64-1
Etigilimab 2044984-83-8
Orilanolimab 2066544-85-0
Sintilimab (anti-PD-1) 2072873-06-2
91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007©  ChemicalBook. All rights reserved.